These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5978522)

  • 1. Dr. Goddard: firm hand on drug safety.
    Foster JT
    Mod Hosp; 1966 Nov; 107(5):99-100. PubMed ID: 5978522
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA still faces questions on drug safety.
    Med Health; 2005 Mar; 59(6 Spec no.):9-11. PubMed ID: 17063621
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety-related drug labeling changes approved by FDA.
    White GG
    J Toxicol Clin Toxicol; 1998; 36(3):265-7. PubMed ID: 9678979
    [No Abstract]   [Full Text] [Related]  

  • 4. How safe are they?
    Gorman C
    Time; 2004 Nov; 164(22):151. PubMed ID: 15631007
    [No Abstract]   [Full Text] [Related]  

  • 5. Dr. Goddard and the PMA.
    Rev Allergy; 1969 Mar; 23(3):161-3. PubMed ID: 5786222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Letters from Washington. Food and Drug Administration and medical technology: at an impasse?].
    Gelijns AC
    Ned Tijdschr Geneeskd; 1993 Jan; 137(3):146-50. PubMed ID: 8423866
    [No Abstract]   [Full Text] [Related]  

  • 7. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
    Murphy S; Roberts R
    J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 9. The NARD and Dr. Goddard.
    Provost GP
    Am J Hosp Pharm; 1968 Feb; 25(2):59. PubMed ID: 5643645
    [No Abstract]   [Full Text] [Related]  

  • 10. The drug safety review process.
    Somberg J
    Am J Ther; 2007; 14(2):119. PubMed ID: 17414577
    [No Abstract]   [Full Text] [Related]  

  • 11. An interview with Dr. James L. Goddard.
    Callahan B
    Hosp Prog; 1967 Sep; 48(9):62-6. PubMed ID: 6073602
    [No Abstract]   [Full Text] [Related]  

  • 12. The FDA and the fight against terrorism.
    Meadows M
    FDA Consum; 2004; 38(1):20-7. PubMed ID: 15032200
    [No Abstract]   [Full Text] [Related]  

  • 13. Keeping up with drug safety information.
    Meadows M
    FDA Consum; 2006; 40(3):38-9. PubMed ID: 16906667
    [No Abstract]   [Full Text] [Related]  

  • 14. Your health in the 21st century. A better safety net.
    Rosenberg D
    Newsweek; 2005; 145(26A):70-2. PubMed ID: 16375152
    [No Abstract]   [Full Text] [Related]  

  • 15. LyphoMed sparks worries.
    Wagner M
    Mod Healthc; 1988 Jul; 18(29):5. PubMed ID: 10325202
    [No Abstract]   [Full Text] [Related]  

  • 16. What's best for the patient?
    Burkle WS
    Am J Hosp Pharm; 1983 Apr; 40(4):558. PubMed ID: 6846359
    [No Abstract]   [Full Text] [Related]  

  • 17. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(44):10944-7. PubMed ID: 10557618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
    Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW
    Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug safety and the role of clinical pharmacology in the safe use of therapeutics.
    Honig PK
    Clin Pharmacol Ther; 2009 Mar; 85(3):225-8. PubMed ID: 19223873
    [No Abstract]   [Full Text] [Related]  

  • 20. Beware of new drugs, study suggests.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.